- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: drug interactions CYP3A4 CYP3A5 midazolam anti-rheumatic agents
Total 260040 results
-
Yonsei UniversityInje UniversityCompletedBreast Neoplasms | Antineoplastic Agents | Therapeutic Uses | Survival AnalysisKorea, Republic of
-
Vantia LtdCompleted
-
GlaxoSmithKlineCompletedNausea and Vomiting, Chemotherapy-InducedUnited States
-
Astellas Pharma IncCompletedPharmacokinetics of YM178United States
-
Vanda PharmaceuticalsCross Research S.A.CompletedHealthy VolunteersSwitzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerUnited States
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBelgium
-
Boehringer IngelheimCompleted
-
All India Institute of Medical Sciences, New DelhiUniversity of ZurichCompleted
-
Northwestern UniversityPurdue UniversityCompletedPregnancy RelatedUnited States
-
Janssen Research & Development, LLCCompleted
-
H. Lundbeck A/SCompleted
-
Millennium Pharmaceuticals, Inc.Completed
-
Janssen Research & Development, LLCCompleted
-
Insmed IncorporatedCompletedHealthy VolunteersUnited States
-
BayerOrion Corporation, Orion PharmaCompletedBiological AvailabilityGermany
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedMultiple Myeloma | Non-Hodgkin's LymphomaIsrael, Italy, Poland, South Africa, United Kingdom
-
University Hospital, Clermont-FerrandCompletedHyperalgesia | Experimental PainFrance
-
Novartis PharmaceuticalsWithdrawnLeukemia, Myeloid, Acute
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, Poland
-
BayerOrion Corporation, Orion PharmaCompleted
-
GlaxoSmithKlineCompletedSleep Initiation and Maintenance DisordersGermany
-
Boehringer IngelheimCompleted
-
Acerta Pharma BVCompleted
-
Peking University People's HospitalYichang Humanwell Pharmaceutical Co., Ltd., ChinaUnknown
-
R-Pharm International, LLCIQVIA RDS Ireland Ltd; Thermo Fisher Scientific FSCompletedRheumatoid ArthritisBulgaria, Moldova, Republic of
-
Concert PharmaceuticalsCompleted
-
CTI BioPharmaCovanceCompleted
-
Cyclerion TherapeuticsCompleted
-
Millennium Pharmaceuticals, Inc.CompletedHealthy ParticipantsUnited States
-
PfizerCompleted
-
Clementia Pharmaceuticals Inc.CompletedFibrodysplasia Ossificans ProgressivaUnited States
-
University Medicine GreifswaldCompletedPharmacokinetics | Pharmacodynamics | Drug Interactions | Intestinal Transporter ExpressionGermany
-
Novartis PharmaceuticalsMedicines for Malaria VentureCompleted
-
Eisai Inc.Completed
-
Dizal PharmaceuticalsRecruiting
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Cyclerion TherapeuticsCompleted
-
TakedaCompleted
-
Institute of Liver and Biliary Sciences, IndiaRecruiting
-
Thomas Jefferson UniversityBristol-Myers SquibbCompletedHealthy | Venous Thromboembolism | PharmacokineticsUnited States
-
Repros Therapeutics Inc.CompletedDrug InteractionsUnited States
-
Eisai Inc.Completed
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Janssen Research & Development, LLCCompleted
-
Daiichi Sankyo, Inc.Completed
-
AHEPA University HospitalSkylitseio General HospitalCompletedAtrial Fibrillation | Arrhythmias, CardiacGreece
-
Eisai Inc.Completed
-
AstraZenecaCompletedSolid TumoursBelgium, Denmark, United Kingdom, Netherlands